Sage Therapeutics
SAGE
$11.90
Share price
-3.57%
Change (1 day)
-77.39%
Change (1 year)
Categories
Operating Margin for Sage Therapeutics (SAGE)
Operating Margin as of May 2024 (TTM): -5,932.08%
According to Sage Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -5,932.08%. At the end of 2022 the company had an Operating Margin of -6,931.88%.
Operating Margin history for Sage Therapeutics from 2019 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -6,931.88% | -4.51% |
| 2021 | -7,258.91% | -13444.72% |
| 2020 | 54.40% | -100.55% |
| 2019 | -9,904.46% | 2297.82% |
| 2018 | -413.06% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | -119.48% | -97.99% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | -59.02% | -99.01% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | 14.06% | -100.24% | 🇮🇪 Ireland |
 Eagle Pharmaceuticals
EGRX | 21.96% | -100.37% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.